Cite
The regrouping of Luminal B (HER2 negative), a better discriminator of outcome and recurrence score.
MLA
Yang, Zheng‐Jun, et al. “The Regrouping of Luminal B (HER2 Negative), a Better Discriminator of Outcome and Recurrence Score.” Cancer Medicine, vol. 12, no. 3, Feb. 2023, pp. 2493–504. EBSCOhost, https://doi.org/10.1002/cam4.5089.
APA
Yang, Z., Liu, Y., Huang, Y., Chen, Z., Zhang, H., Yu, Y., Wang, X., & Cao, X. (2023). The regrouping of Luminal B (HER2 negative), a better discriminator of outcome and recurrence score. Cancer Medicine, 12(3), 2493–2504. https://doi.org/10.1002/cam4.5089
Chicago
Yang, Zheng‐Jun, Yu‐Xiao Liu, Yue Huang, Zu‐Jin Chen, Hao‐Zhi Zhang, Yue Yu, Xin Wang, and Xu‐Chen Cao. 2023. “The Regrouping of Luminal B (HER2 Negative), a Better Discriminator of Outcome and Recurrence Score.” Cancer Medicine 12 (3): 2493–2504. doi:10.1002/cam4.5089.